Vasculitis clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
open to eligible people ages 18 years and up
Patients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for development of medical therapy for DVB aneurysms
San Francisco, California
Our lead scientists for Vasculitis research studies include Daniel L Cooke, MD.
Last updated: